Search Within

Robert Motzer

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (50)
  2. Meeting Abstract (33)
  3. Correspondence (1)
  4. Review (1)
Groups
  1. Department of Medicine (85)
  2. Genitourinary Oncology Service (85)
  3. Sloan Kettering Institute Postdocs (85)
  4. Solid Tumor Oncology Division (85)
  5. Human Oncology and Pathogenesis Program (66)
  6. Surgery (64)

More Groups

People
  1. Abraham Hakimi (60)
  2. Martin Voss (60)
  3. Paul Russo (42)
  4. Yingbei Chen (36)
  5. Jonathan Coleman (34)
  6. Renzo Dinatale (28)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (8)
  5. 2021 (9)
  6. 2020 (11)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. BJU International (7)
  3. Clinical Cancer Research (6)
  4. European Urology Focus (6)
  5. Urologic Oncology: Seminars and Original Investigations (4)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. American Association for Cancer Research (13)
  3. Elsevier Inc. (9)
  4. Wiley Blackwell (9)
  5. Elsevier Science, Inc. (8)
  6. Elsevier B.V. (7)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors for survival in patients undergoing surveillance after cytoreductive nephrectomy
    Journal Article

    Reese, S. W.; Khaleel, S.; Silagy, A.; Xie, A.; Eismann, L.; Vazquez-Rivera, K.; Oparanozie, A.; Patil, S.; Coleman, J.; Motzer, R.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Reply by authors
    Correspondence

    Reese, S. W.; Khaleel, S.; Silagy, A.; Xie, A.; Eismann, L.; Vazquez-Rivera, K.; Oparanozie, A.; Patil, S.; Coleman, J.; Motzer, R.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Clinical and immunogenomic outcomes of consolidative cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint blockade
    Meeting Abstract

    Reese, S. W.; Jiang, H.; Kuo, F.; Wu, C. Y.; Vuong, L.; Mascareno, E.; Oparanozie, A.; Motzer, R. J.; Voss, M. H.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Biomarker analysis from the phase 3 CheckMate 9ER trial of nivolumab + cabozantinib v sunitinib for advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Choueiri, T. K.; Motzer, R. J.; Powles, T.; Burotto, M.; Apolo, A. B.; Escudier, B.; Tomita, Y.; McDermott, D. F.; Braun, D. A.; Han, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic and metabolic hallmarks of SDH- and FH-deficient renal cell carcinomas
    Journal Article

    Yoo, A.; Tang, C.; Zucker, M.; Fitzgerald, K.; DiNatale, R. G.; Rappold, P. M.; Weiss, K.; Freeman, B.; Lee, C. H.; Schultz, N.; more...
    European Urology Focus (2022)

    Fulltext@MSK | Save
  • Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
    Journal Article

    Golkaram, M.; Kuo, F.; Gupta, S.; Carlo, M. I.; Salmans, M. L.; Vijayaraghavan, R.; Tang, C.; Makarov, V.; Rappold, P.; Blum, K. A.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save
  • Molecular profile and clinical outcomes of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Meeting Abstract

    Ma, J.; del Balzo, L.; Khaleel, S. S.; Flynn, J.; Zhang, Z.; Voss, M. H.; Freeman, B.; Hakimi, A. A.; Lee, C. H.; Eichholz, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC
    Meeting Abstract

    Khaleel, S. S.; Liu, M.; Kuo, F.; Kotecha, R.; Lee, C. H.; Voss, M. H.; Motzer, R. J.; Hakimi, A. A.; Reznik, E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A targetable myeloid inflammatory state governs disease recurrence in clear-cell renal cell carcinoma
    Journal Article

    Rappold, P. M.; Vuong, L.; Leibold, J.; Chakiryan, N. H.; Curry, M.; Kuo, F.; Sabio, E.; Jiang, H.; Nixon, B. G.; Liu, M.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save